DJIA 17,071.22 -41.93 -0.25%
NASDAQ 4,505.85 -6.34 -0.14%
S&P 500 1,977.80 -5.05 -0.25%
market minute promo

130.26 1.27 (0.98%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $130.26 0.98%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $127.64
Previous Close $128.99
Daily Range $126.69 - $131.85
52-Week Range $102.60 - $153.10
Market Cap $43.7B
P/E Ratio -54.89
Dividend (Yield) $0.00 (0.0%)
Volume 2,663,223
Average Daily Volume 2,338,425
Current FY EPS $2.96

Sector

Healthcare

Industry

Drugs

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary

3 Questions for Allergan Inc.

Allergan is fighting tooth and nail to remain independent from Valeant Pharmaceuticals. Here are three questions investors should know the answers to heading into what is looking like the endgame.

Today's Stocks Driving Success For The Drugs Industry

UPDATE: Allergan Board Offers Statement, Says Valeant's Bid 'Grossly Inadequate'

Jackson Square Partners Joins Investors Opposing Allergan Bid for Salix

Allergan Writes Back, Coaxes Shareholders Against Valeant - Analyst Blog

Allergan Writes Back, Coaxes Shareholders Against Valeant - Analyst Blog

Why Allergan (AGN) Stock Is Declining in After-Hours Trading Today

Can Valeant's Glaucoma Drug Peak Sales Be Much Lower Than Claimed?

Valeant (VRX) Sends Letter to Allergan, Provides Q3 Update - Analyst Blog

Valeant (VRX) Sends Letter to Allergan, Provides Q3 Update - Analyst Blog

Valeant Pharmaceuticals (VRX) in Focus: Stock Adds 6.9% - Tale of the Tape

Valeant Pharmaceuticals International (VRX) Leads The Pack In Pre-Market Activity

Update: Valeant's Q3 Shocker Devoid Of Details; Allergan Claims It Will Win In The Special Meeting A

Update: Valeant's Q3 Shocker Devoid Of Details; Allergan Claims It Will Win In The Special Meeting And Looks Forward To It

See More VRX News...

VRX's Top Competitors

VRX $130.26 (0.98%)
Current stock: VRX
JNJ $106.54 (-0.52%)
Current stock: JNJ
NVS $93.56 (0.41%)
Current stock: NVS
RHHBY $36.90 (-0.24%)
Current stock: RHHBY